<DOC>
	<DOC>NCT01754194</DOC>
	<brief_summary>Study objectives: 1. generate local clinical, health-related quality-of-life and health economic data to evaluate the benefits of two types of minimally invasive weight-loss surgery 2. support multi-disciplinary bariatric sites in Germany by providing structured procedure guidelines and training, therefore facilitating procedural adoption, increasing safety and shortening the learning curve for weight-loss surgery.</brief_summary>
	<brief_title>Clinical and Economic Outcomes in Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass Surgery</brief_title>
	<detailed_description>The objectives of this study are the following: to generate local clinical, health-related quality-of-life and health economic data to evaluate the benefits of two types of minimally invasive weight-loss surgery; and to support multi-disciplinary bariatric sites in Germany by providing structured procedure guidelines and training, therefore facilitating procedural adoption, increasing safety and shortening the learning curve for weight-loss surgery.</detailed_description>
	<mesh_term>Obesity, Morbid</mesh_term>
	<criteria>All patients aged from 18 to 65 years of age, inclusive BMI &gt; 40 or BMI &gt; 35 with comorbidities Eligible for weightloss surgery Planned laparoscopic gastric sleeve resections or RouxenY bypass surgery Insurance approval status: approved Written informed consent BMI &gt; 55 Planned twostage procedures Prior bariatric procedures (including gastric banding) Serious mental or physical comorbidities at the discretion of the Investigator Insurance approval status: rejected</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Gastric Sleeve</keyword>
	<keyword>Gastric Bypass</keyword>
	<keyword>Roux en Y</keyword>
	<keyword>Morbid Obesity</keyword>
	<keyword>Laparoscopy</keyword>
</DOC>